Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex

Cell
2020
Changrui Xing ∙ Youwen Zhuang ∙ Ting-Hai Xu ∙ Zhiwei Feng ∙ X. Edward Zhou ∙ Maozi Chen ∙ Lei Wang ∙ Xing Meng ∙ Ying Xue ∙ Junmei Wang ∙ Heng Liu ∙ Terence Francis McGuire ∙ Gongpu Zhao ∙ Karsten Melcher ∙ Cheng Zhang ∙ H. Eric ∙ Xiang-Qun Xie

Summary

Drugs selectively targeting CB2 hold promise for treating neurodegenerative disorders, inflammation, and pain while avoiding psychotropic side effects mediated by CB1. The mechanisms underlying CB2 activation and signaling are poorly understood but critical for drug design. Here we report the cryo-EM structure of the human CB2-Gi signaling complex bound to the agonist WIN 55,212-2. The 3D structure reveals the binding mode of WIN 55,212-2 and structural determinants for distinguishing CB2 agonists from antagonists, which are supported by a pair of rationally designed agonist and antagonist. Further structural analyses with computational docking results uncover the differences between CB2 and CB1 in receptor activation, ligand recognition, and Gi coupling. These findings are expected to facilitate rational structure-based discovery of drugs targeting the cannabinoid system.

This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.